Trials / Conditions / Lymphoma Diffuse Large B-cell
Lymphoma Diffuse Large B-cell
6 registered clinical trials studyying Lymphoma Diffuse Large B-cell — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers NCT07226843 | Eli Lilly and Company | Phase 1 |
| Recruiting | Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B- NCT07284433 | AvenCell Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Pati NCT06777290 | Charles University, Czech Republic | — |
| Completed | Pesticide Associated Lymphomas: Expression of Treatment Resistance Genes NCT03597685 | University Hospital, Montpellier | — |
| Terminated | Occupational Exposure to Pesticides in the Prognosis of Lymphomas NCT02898870 | University Hospital, Montpellier | — |
| Completed | PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) NCT02226965 | Sierra Oncology LLC - a GSK company | Phase 2 |